Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition

Neuroscience Letters

Volumn 380, Issue 1-2, 2005, Pages 93-98

  Miwa, Hideto ^a   Kubo, Tomomi ^a   Suzuki, Ai ^a   Nishi, Katsunori ^b   Kondo, Tomoyoshi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Lactacystin; Oxidative stress; Proteasome; Rat; Substantia nigra

Indexed keywords

ALPHA SYNUCLEIN; HEME OXYGENASE 1; LACTACYSTIN; PROTEASOME; PROTEASOME INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CELL INCLUSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; MALE; NERVE DEGENERATION; NERVE ENDING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 18044380520     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.01.024     Document Type: Article

References (26)

1. + can disrupt the nigrostriatal dopamine system by acting in the terminal area Neuropharmacology 25 1986 939 941
2. D.F. Clayton, and J.M. George The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease Trends Neurosci. 21 1998 249 254
3. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822
4. Q. Ding, and J.N. Keller Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins J. Neurochem. 77 2001 1010 1017
5. G. Di Rosa, D. Puzzo, A. Sant'Angelo, F. Trinchese, and O. Arancio Alpha-synuclein: between synaptic function and dysfunction Histol. Histopathol. 18 2003 1257 1266
6. H. Drexler Activation of the cell death program by inhibition of proteasome function Proc. Natl. Acad. Sci. U.S.A. 94 1997 855 860
7. B.F. El-Khodor, and R.E. Burke Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons J. Comp. Neurol. 452 2002 65 79
8. G. Forloni, L. Terreni, I. Bertani, S. Fogliarino, R. Invernizzi, A. Assini, G. Ribizzi, A. Negro, E. Calabrese, M.A. Volonte, C. Mariani, M. Franceschi, M. Tabaton, and A. Bertoli Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms Neurobiol. Aging 23 2002 957 976
9. F. Fornai, P. Lenzi, M. Gesi, M. Ferrucci, G. Lazzeri, C.L. Busceti, R. Ruffoli, P. Soldani, S. Ruggieri, M.G. Alessandri, and A. Paparelli Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition J. Neurosci. 23 2003 8955 8966
10. B. Halliwell Hypothesis: proteasomal dysfunction: a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death Ann. N.Y. Acad. Sci. 962 2002 182 194
11. Y. Imai, M. Soda, H. Inoue, N. Hattori, Y. Mizuno, and R. Takahashi An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a subset of Parkin Cell 105 2001 891 902
12. B. Kaplan, V. Ratner, and E. Haas Alpha-synuclein: its biological function and role in neurodegenerative diseases J. Mol. Neurosci. 20 2003 83 92
13. S.I. Kubo, T. Kitami, S. Noda, H. Shimura, Y. Uchiyama, S. Asakawa, S. Minoshima, N. Shimizu, Y. Mizuno, and N. Hattori Parkin is associated with cellular vesicles J. Neurochem. 78 2001 42 54
14. J.Y. Li, P. Henning Jensen, and A. Dahlstrom Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS Neuroscience 113 2002 463 478
15. U. Lopes, P. Ernhardt, R. Yao, and G. Cooper p53-dependent induction of apoptosis by proteasome inhibitors J. Biol. Chem. 272 1997 12893 12896
16. K.S. McNaught, L.M. Björklund, R. Belzaire, O. Isacson, P. Jenner, and C.W. Olanow Proteasome inhibition causes nigral degeneration with inclusion bodies in rats NeuroReport 13 2002 1437 1441
17. K.S. McNaught, and C.W. Olanow Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease Ann. Neurol. 53 Suppl. 3 2003 S73 S84
18. K.S. McNaught, D.R. Perl, A.L. Brownell, and C.W. Olanow Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease Ann. Neurol. 56 2004 149 162
19. + NeuroReport 29 2004 1039 1044
20. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates second ed. 1986 Academic Press Sydney
21. J.H. Qiu, A. Asai, S. Chi, N. Saito, H. Hamada, and T. Kirino Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons J. Neurosci. 20 2000 259 265
22. H.J. Rideout, K.E. Larsen, D. Sulzer, and L. Stefanis Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunopositive inclusions in PC12 cells J. Neurochem. 78 2001 899 908
23. H. Sauer, and W.H. Oertel Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401 415
24. H.M. Schipper Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress Ann. N.Y. Acad. Sci. 1012 2004 84 93
25. H.M. Schipper, A. Liberman, and E.G. Stopa Neural heme oxygenase-1 expression in idiopathic Parkinson's disease Exp. Neurol. 150 1998 60 68
26. M.S. Yoo, H.S. Chun, J.J. Son, L.A. DeGiorgio, D.J. Kim, C. Peng, and J.H. Son Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease Brain Res. Mol. Brain Res. 110 2003 76 84